Combining genetic information from a patient's tumor cells with three-dimensional cell cultures grown from these tumors and rapidly screening approved drugs can identify the best treatment approaches in patients for whom ...
Mar 23, 2017
0
33
People with colorectal cancer, the fourth most common cancer in the U.S., are often prescribed unnecessary chemotherapy after their cancer is completely gone.
Dec 29, 2022
0
3
In findings with major implications for the genetics of cancer and human health, researchers at Beth Israel Deaconess Medical Center (BIDMC) and two other science teams in New York City and Rome have uncovered evidence of ...
Oct 13, 2011
0
0
Researchers at the Netherlands Cancer Institute have compiled a detailed catalog of bacteria living in cancer metastases. Having analyzed over 4,000 tumors, they shed light on the diversity of these co-inhabitants and how ...
Apr 9, 2024
0
123
Plant flavonoid luteolin blocks cell signaling pathways in colon cancer cells
Jan 23, 2012
1
0
An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer, an international phase III clinical trial found. The findings were presented ...
Jan 18, 2012
0
0
Cancer is an unwanted experiment in progress. As the disease advances, tumor cells accumulate mutations, eventually arriving at ones that give them the insidious power to grow uncontrollably and spread. Distinguishing drivers ...
Oct 30, 2014
0
0
The concept was simple: If two compounds each individually show promise in preventing colon cancer, surely it's worth trying the two together to see if even greater impact is possible.
Mar 23, 2015
1
126
Colorectal cancer outcomes may improve by genetically altering an immune-regulatory protein in cancer cells, making the cells more vulnerable to chemotherapy. That's according to new Mayo Clinic research.
Aug 26, 2019
0
10
The more scientists explore so-called "junk" DNA, the less the label seems to fit.
Aug 14, 2018
0
65
